top of page

Feline Acute Neutrophilic Cholangitis (Suppurative Cholangiohepatitis)


1.

Definition



Acute neutrophilic cholangitis is an inflammatory hepatobiliary disorder in cats characterized by neutrophilic infiltration of the intrahepatic bile ducts and portal areas. This condition often results from ascending bacterial infections originating from the gastrointestinal tract.




2.

Species Commonly Affected



  • Domestic cats, particularly middle-aged to older individuals.

  • Breeds with predispositions include Siamese and Persian cats.





3.

Etiology



  • Primary Cause: Ascending bacterial infection from the gastrointestinal tract.

  • Common Bacterial Isolates:


    • Escherichia coli

    • Enterococcus spp.

    • Clostridium spp.

    • Streptococcus spp.

    • Bacteroides spp.


  • Predisposing Factors:


    • Anatomical proximity of the feline common bile duct and pancreatic duct, facilitating bacterial migration.

    • Concurrent gastrointestinal diseases, such as inflammatory bowel disease or pancreatitis.






4.

Detailed Pathophysiology



In cats, the common bile duct and pancreatic duct often merge before entering the duodenum. This anatomical configuration allows for the potential retrograde movement of bacteria from the small intestine into the biliary system.


Once bacteria ascend into the biliary tract, they incite an acute inflammatory response characterized by:


  • Neutrophilic Infiltration: Neutrophils migrate into the bile ducts and surrounding hepatic tissue, leading to cholangitis and potentially cholangiohepatitis if hepatic parenchyma is involved.

  • Bile Duct Obstruction: Inflammation and edema can obstruct bile flow, resulting in cholestasis and hepatocellular injury.

  • Hepatocellular Damage: Prolonged inflammation may lead to hepatocyte necrosis, fibrosis, and, in chronic cases, cirrhosis.





5.

Clinical Signs



  • Lethargy

  • Anorexia

  • Vomiting

  • Weight loss

  • Icterus (jaundice)

  • Fever

  • Abdominal discomfort or pain

  • Dehydration  





6.

Diagnostic Methods



  • Laboratory Tests:


    • Complete Blood Count (CBC): Leukocytosis with a left shift, neutrophilia.

    • Serum Biochemistry:


      • Elevated liver enzymes: ALT, AST, ALP, GGT.

      • Hyperbilirubinemia.

      • Elevated bile acids.



  • Imaging:


    • Abdominal Ultrasound:


      • Enlarged, hyperechoic liver.

      • Dilated bile ducts.

      • Gallbladder abnormalities (e.g., sludge, wall thickening).



  • Definitive Diagnosis:


    • Liver Biopsy:


      • Histopathology revealing neutrophilic infiltration of bile ducts and portal areas.

      • Culture and sensitivity testing of bile or liver tissue to identify causative bacteria.







7.

Treatment Options



Medical Management:


  • Antimicrobial Therapy:


    • Empirical broad-spectrum antibiotics targeting gram-negative and anaerobic bacteria:


      • Ampicillin: 20 mg/kg IV every 8 hours.

      • Enrofloxacin: 5 mg/kg IV or PO once daily.

      • Metronidazole: 10–15 mg/kg PO every 12 hours.


    • Adjust antibiotics based on culture and sensitivity results.


  • Supportive Care:


    • Fluid Therapy: Correct dehydration and electrolyte imbalances.

    • Nutritional Support: High-quality, easily digestible diet; consider feeding tube placement if anorexia persists.

    • Hepatoprotective Agents:


      • S-Adenosylmethionine (SAMe): 20 mg/kg PO once daily.

      • Vitamin E: 10 IU/kg PO once daily.



  • Choleretic Agents:


    • Ursodeoxycholic Acid: 10–15 mg/kg PO once daily; promotes bile flow and has immunomodulatory effects.


  • Analgesia:


    • Buprenorphine: 0.01–0.02 mg/kg IV or transmucosal every 8–12 hours for pain management.  




Surgical Intervention:


  • Indicated in cases with biliary obstruction, gallbladder rupture, or cholelithiasis.

  • Procedures:


    • Cholecystectomy: Surgical removal of the gallbladder.

    • Biliary Decompression: Placement of a biliary stent or external drainage.

    • Bile Duct Exploration: Removal of obstructive choleliths or debris.


  • Postoperative Care:


    • Continued antimicrobial therapy.

    • Monitoring for signs of bile leakage or peritonitis.

    • Supportive care as outlined above.






8.

Complications / Prognosis



Complications of Feline Acute Neutrophilic Cholangitis (Suppurative Cholangiohepatitis)



Complication

Pathogenesis

Clinical Consequence

Biliary Obstruction

Edema, cellular debris, or choleliths within bile ducts → mechanical blockage

Extrahepatic bile duct obstruction (EHBO) → marked hyperbilirubinemia, icterus, hepatocellular injury

Gallbladder Mucocele or Rupture

Increased gallbladder wall tension from inflammation or infection → rupture

Bile peritonitis → septic shock, severe peritonitis, high mortality

Hepatic Abscess Formation

Persistent localized bacterial infection within hepatic parenchyma

May require surgical drainage; risk of systemic bacteremia

Septicemia / Systemic Inflammatory Response Syndrome (SIRS)

Ascending bacterial infection enters bloodstream

Systemic hypotension, hypoglycemia, DIC, multi-organ dysfunction

Chronic Cholangitis / Fibrosis

Ongoing inflammation promotes fibroblast activation and scarring

Irreversible hepatic fibrosis, biliary cirrhosis, liver failure

Pancreatitis

Shared pancreaticobiliary duct in cats allows concurrent infection

Vomiting, abdominal pain, systemic illness, worsened prognosis

Hepatic Encephalopathy

Hepatic insufficiency leading to ammonia accumulation

Neurologic signs: ptyalism, ataxia, seizures, coma

Coagulopathies

Liver dysfunction impairs production of coagulation factors (esp. II, VII, IX, X)

Spontaneous bleeding, prolonged clotting times (PT, aPTT)

Portal Hypertension

Fibrosis impeding portal blood flow

Ascites, acquired portosystemic shunts, GI bleeding


Prognosis:


Factor

Prognosis Impact

Early diagnosis + aggressive medical management

Favorable to good

Presence of biliary obstruction, rupture, or septic peritonitis

Guarded to poor

Progression to chronic cholangitis or cirrhosis

Poor long-term prognosis

Multi-organ involvement (pancreatitis, IBD)

Complicates management, worsens prognosis

9. Zoonotic Potential

None reported

  • The bacteria involved (E. coli, Clostridium, Enterococcus, etc.) are zoonotic in certain contexts but not through direct transmission of feline cholangitis.

  • Standard hygiene precautions for veterinary staff when handling bile or infected tissues are recommended.

10. NAVLE-Specific Tips

  • Most common type of feline cholangitis = Neutrophilic (acute suppurative)

  • Ascending infection due to unique feline biliary anatomy → shared bile and pancreatic duct in cats.

  • Common bacteria = E. coli, anaerobes

  • Treatment = broad-spectrum antibiotics (Ampicillin + Enrofloxacin + Metronidazole)

  • Do not forget Ursodeoxycholic Acid → increases bile flow

  • Liver biopsy = gold standard

  • Complications = EHBO, septic peritonitis, pancreatitis

  • Remember association with "triaditis" = IBD + Pancreatitis + Cholangitis in cats

11. References (Veterinary Professional Sources Only)

Do you have any feedback about the Quick Note?

We'd love to hear from you!

Feel free to send us a message

 

Don't forget to share with any friends who are also

preparing for the NAVLE Test.

AllVetsLink NAVLE Prep Sections:

Untitled_Artwork 12.png

Dogs

Untitled_Artwork 9.png

Bovine

Untitled_Artwork 11.png

Cats

Untitled_Artwork 8.png

Pigs

Untitled_Artwork 10.png

Horses

Untitled_Artwork 7.png

Other Species

Untitled_Artwork 1 2.png

Other Topics

🐾 Sobre AllVetsLink:

AllVetsLink es una plataforma bilingüe dedicada a compartir información veterinaria clara, útil y basada en ciencia — para profesionales de la salud animal y personas que cuidan y aman a sus mascotas.

Legal:

  • Términos de uso

  • Política de privacidad

  • Aviso legal

  • Copyright © [2025] AllVetsLink.

    • Todos los derechos reservados.

  • Creado por DVM Paola M. Estanol

    • @Dr.PaMoEs

Idiomas:

🇨🇦 English | 🇲🇽 Español

Conéctate:

  • White Facebook Icon
  • White Instagram Icon
  • White Twitter Icon
logovetslink1.png
bottom of page